Skip to main content
Top
Published in: Inflammation 1/2018

01-02-2018 | ORIGINAL ARTICLE

Functional Role of SUV39H1 in Human Renal Tubular Epithelial Cells Under High-glucose Ambiance

Authors: Jiayi Wang, Wenzhe Yan, Xiaofei Peng, Yafeng Jiang, Liyu He, Youming Peng, Xian Chen, Muyao Ye, Hui Zhuo

Published in: Inflammation | Issue 1/2018

Login to get access

Abstract

SUV39H1, the histone methyltransferase (HMTase) of histone H3 lysine 9 trimethylation (H3K9me3), is a known transcriptional repressor of inflammatory genes. The effect of SUV39H1 on inflammatory gene promoters under high-glucose stimulation in vascular smooth muscle cells (VSMCs), macrophages, and cardiomyocytes has been studied, but how SUV39H1 functions in renal tubules under diabetic conditions is unclear. Renal biopsy specimens of ten diabetic nephropathy (DN) subjects and seven non-DN minimal change diseases (MCD) subjects were collected. SUV39H1, IL-6, and MCP-1 expression in renal tissues were measured using immunohistochemical, while SUV39H1, H3K9me3, IL-6, and MCP-1 in human proximal tubular epithelial cells (HK-2) under varying glucose conditions were assayed by Western blot and ELISA. SUV39H1 was overexpressed in HK-2 cells; the regulation of SUV39H1 and H3K9me3 on NF-κB, IL-6, MCP-1, caspase 3, and apoptosis was measured. SUV39H1 was expressed more in diabetic human renal tubules. HK-2 cells with high glucose up-regulated IL-6 and MCP-1 in a dose- and time-dependent manner, and SUV39H1 expression was reduced with greater glucose and prolonged stimulation. Expression of H3K9me3 was synchronized with SUV39H1. Moreover, overexpression of SUV39H1 in high glucose environment was accompanied with increased H3K9me3 and decreased inflammation and apoptosis. SUV39H1 dysregulation may be involved in DN progression. Overexpression of SUV39H1 may reduce renal inflammation and apoptosis via epigenetic modulation, thus plays a protective role in DN.
Literature
1.
go back to reference Guariguata, L., D.R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J.E. Shaw. 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice 103: 137–149.CrossRefPubMed Guariguata, L., D.R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J.E. Shaw. 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice 103: 137–149.CrossRefPubMed
2.
go back to reference Cooper, M.E. 2012. Diabetes: treating diabetic nephropathy-still an unresolved issue. Nature Reviews. Endocrinology 8: 515–516.CrossRefPubMed Cooper, M.E. 2012. Diabetes: treating diabetic nephropathy-still an unresolved issue. Nature Reviews. Endocrinology 8: 515–516.CrossRefPubMed
3.
go back to reference Kanwar, Y.S., L. Sun, P. Xie, F.Y. Liu, and S. Chen. 2011. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual Review of Pathology 6: 395–423.CrossRefPubMedPubMedCentral Kanwar, Y.S., L. Sun, P. Xie, F.Y. Liu, and S. Chen. 2011. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual Review of Pathology 6: 395–423.CrossRefPubMedPubMedCentral
4.
go back to reference Hasegawa, G., K. Nakano, M. Sawada, K. Uno, Y. Shibayama, K. Ienaga, and M. Kondo. 1991. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney International 40: 1007–1012.CrossRefPubMed Hasegawa, G., K. Nakano, M. Sawada, K. Uno, Y. Shibayama, K. Ienaga, and M. Kondo. 1991. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney International 40: 1007–1012.CrossRefPubMed
5.
go back to reference Suzuki, D., M. Miyazaki, R. Naka, T. Koji, M. Yagame, K. Jinde, M. Endoh, Y. Nomoto, and H. Sakai. 1995. In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 44: 1233–1238.CrossRefPubMed Suzuki, D., M. Miyazaki, R. Naka, T. Koji, M. Yagame, K. Jinde, M. Endoh, Y. Nomoto, and H. Sakai. 1995. In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 44: 1233–1238.CrossRefPubMed
6.
go back to reference Navarro, J.F., C. Mora, M. Maca, and J. Garca. 2003. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases 42: 53–61.CrossRefPubMed Navarro, J.F., C. Mora, M. Maca, and J. Garca. 2003. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases 42: 53–61.CrossRefPubMed
7.
go back to reference Moriwaki, Y., T. Yamamoto, Y. Shibutani, E. Aoki, Z. Tsutsumi, S. Takahashi, H. Okamura, M. Koga, M. Fukuchi, and T. Hada. 2003. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52: 605–608.CrossRefPubMed Moriwaki, Y., T. Yamamoto, Y. Shibutani, E. Aoki, Z. Tsutsumi, S. Takahashi, H. Okamura, M. Koga, M. Fukuchi, and T. Hada. 2003. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52: 605–608.CrossRefPubMed
8.
go back to reference Wei, Q., G. Dong, J.K. Chen, G. Ramesh, and Z. Dong. 2013. Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule-specific knockout mouse models. Kidney International 84: 138–148.CrossRefPubMedPubMedCentral Wei, Q., G. Dong, J.K. Chen, G. Ramesh, and Z. Dong. 2013. Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule-specific knockout mouse models. Kidney International 84: 138–148.CrossRefPubMedPubMedCentral
10.
go back to reference Kato, M., and R. Natarajan. 2014. Diabetic nephropathy—emerging epigenetic mechanisms. Nature Reviews. Nephrology 10: 517–530.CrossRefPubMed Kato, M., and R. Natarajan. 2014. Diabetic nephropathy—emerging epigenetic mechanisms. Nature Reviews. Nephrology 10: 517–530.CrossRefPubMed
11.
go back to reference Villeneuve, L.M., M.A. Reddy, L.L. Lanting, M. Wang, L. Meng, and R. Natarajan. 2008. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proceedings of the National Academy of Sciences of the United States of America 105: 9047–9052.CrossRefPubMedPubMedCentral Villeneuve, L.M., M.A. Reddy, L.L. Lanting, M. Wang, L. Meng, and R. Natarajan. 2008. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proceedings of the National Academy of Sciences of the United States of America 105: 9047–9052.CrossRefPubMedPubMedCentral
12.
go back to reference Keating, S.T., and A. El-Osta. 2013. Glycemic memories and the epigenetic component of diabetic nephropathy. Current Diabetes Reports 13: 574–581.CrossRefPubMed Keating, S.T., and A. El-Osta. 2013. Glycemic memories and the epigenetic component of diabetic nephropathy. Current Diabetes Reports 13: 574–581.CrossRefPubMed
13.
go back to reference Li, M.F., R. Zhang, T.T. Li, M.Y. Chen, L.X. Li, J.X. Lu, and W.P. Jia. 2016. High glucose increases the expression of inflammatory cytokine genes in macrophages through H3K9 methyltransferase mechanism. Journal of Interferon & Cytokine Research 36: 48–61.CrossRef Li, M.F., R. Zhang, T.T. Li, M.Y. Chen, L.X. Li, J.X. Lu, and W.P. Jia. 2016. High glucose increases the expression of inflammatory cytokine genes in macrophages through H3K9 methyltransferase mechanism. Journal of Interferon & Cytokine Research 36: 48–61.CrossRef
14.
go back to reference Yang, B., J. Yang, J. Bai, P. Pu, J. Liu, F. Wang, and B. Ruan. 2014. Suv39h1 protects from myocardial ischemia-reperfusion injury in diabetic rats. Cellular Physiology and Biochemistry 33: 1176–1185.CrossRefPubMed Yang, B., J. Yang, J. Bai, P. Pu, J. Liu, F. Wang, and B. Ruan. 2014. Suv39h1 protects from myocardial ischemia-reperfusion injury in diabetic rats. Cellular Physiology and Biochemistry 33: 1176–1185.CrossRefPubMed
15.
go back to reference Zhu, X., X. Xiong, S. Yuan, L. Xiao, X. Fu, Y. Yang, C. Tang, L. He, F. Liu, and L. Sun. 2016. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: a single-center study in China. Journal of Diabetes and its Complications 30: 537–541.CrossRefPubMed Zhu, X., X. Xiong, S. Yuan, L. Xiao, X. Fu, Y. Yang, C. Tang, L. He, F. Liu, and L. Sun. 2016. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: a single-center study in China. Journal of Diabetes and its Complications 30: 537–541.CrossRefPubMed
16.
go back to reference Schotta, G., A. Ebert, and G. Reuter. 2003. SU(VAR)3-9 is a conserved key function in heterochromatic gene silencing. Genetica 117: 149–158.CrossRefPubMed Schotta, G., A. Ebert, and G. Reuter. 2003. SU(VAR)3-9 is a conserved key function in heterochromatic gene silencing. Genetica 117: 149–158.CrossRefPubMed
17.
go back to reference Lachner, M., D. O'Carroll, S. Rea, K. Mechtler, and T. Jenuwein. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116–120.CrossRefPubMed Lachner, M., D. O'Carroll, S. Rea, K. Mechtler, and T. Jenuwein. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116–120.CrossRefPubMed
18.
go back to reference Vaute, O., E. Nicolas, L. Vandel, and D. Trouche. 2002. Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases. Nucleic Acids Research 30: 475–481.CrossRefPubMedPubMedCentral Vaute, O., E. Nicolas, L. Vandel, and D. Trouche. 2002. Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases. Nucleic Acids Research 30: 475–481.CrossRefPubMedPubMedCentral
19.
go back to reference Grgic, I., G. Campanholle, V. Bijol, C. Wang, V.S. Sabbisetti, T. Ichimura, B.D. Humphreys, and J.V. Bonventre. 2012. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney International 82: 172–183.CrossRefPubMedPubMedCentral Grgic, I., G. Campanholle, V. Bijol, C. Wang, V.S. Sabbisetti, T. Ichimura, B.D. Humphreys, and J.V. Bonventre. 2012. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney International 82: 172–183.CrossRefPubMedPubMedCentral
20.
go back to reference Sanz, A.B., M.D. Sanchez-Nino, A.M. Ramos, J.A. Moreno, B. Santamaria, M. Ruiz-Ortega, J. Egido, and A. Ortiz. 2010. NF-kappaB in renal inflammation. Journal of the American Society of Nephrology 21: 1254–1262.CrossRefPubMed Sanz, A.B., M.D. Sanchez-Nino, A.M. Ramos, J.A. Moreno, B. Santamaria, M. Ruiz-Ortega, J. Egido, and A. Ortiz. 2010. NF-kappaB in renal inflammation. Journal of the American Society of Nephrology 21: 1254–1262.CrossRefPubMed
21.
go back to reference Mezzano, S., C. Aros, A. Droguett, M.E. Burgos, L. Ardiles, C. Flores, H. Schneider, M. Ruiz-Ortega, and J. Egido. 2004. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrology, Dialysis, Transplantation 19: 2505–2512.CrossRefPubMed Mezzano, S., C. Aros, A. Droguett, M.E. Burgos, L. Ardiles, C. Flores, H. Schneider, M. Ruiz-Ortega, and J. Egido. 2004. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrology, Dialysis, Transplantation 19: 2505–2512.CrossRefPubMed
22.
go back to reference Zhou, L., D.Y. Xu, W.G. Sha, L. Shen, G.Y. Lu, X. Yin, and M.J. Wang. 2015. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway. Journal of Translational Medicine 13: 352.CrossRefPubMedPubMedCentral Zhou, L., D.Y. Xu, W.G. Sha, L. Shen, G.Y. Lu, X. Yin, and M.J. Wang. 2015. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway. Journal of Translational Medicine 13: 352.CrossRefPubMedPubMedCentral
Metadata
Title
Functional Role of SUV39H1 in Human Renal Tubular Epithelial Cells Under High-glucose Ambiance
Authors
Jiayi Wang
Wenzhe Yan
Xiaofei Peng
Yafeng Jiang
Liyu He
Youming Peng
Xian Chen
Muyao Ye
Hui Zhuo
Publication date
01-02-2018
Publisher
Springer US
Published in
Inflammation / Issue 1/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0657-7

Other articles of this Issue 1/2018

Inflammation 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.